DRIXORAL® ALLERGY/SINUS Extended-Release Tablets combine a nasal decongestant, a non-aspirin pain-reliever, and an antihistamine in a 12-hour timed-release tablet.

  The decongestant temporarily relieves nasal congestion due to sinusitis, the common cold, and hay fever or other upper respiratory allergies. Helps decongest sinus openings and sinus passages; relieves sinus pressure. Reduces swelling of nasal passages; shrinks swollen membranes; and temporarily restores freer breathing through the nose. The pain reliever temporarily relieves headaches, and minor aches and pains. The antihistamine alleviates runny nose, sneezing, itching of the nose or throat, and itchy and watery eyes as may occur in allergic rhinitis (such as hay fever).

Each DRIXORAL® ALLERGY/SINUS Extended-Release Tablet Contains:   60 mg of pseudoephedrine sulfate, 3 mg of dexbrompheniramine maleate, and 500 mg of acetaminophen. These ingredients are released continuously, providing long-lasting relief for 12 hours. Inactive Ingredients: Calcium Phosphate, Carnauba Wax, D&C Yellow No. 10 Aluminum Lake, FD&C Yellow No. 6 Aluminum Lake, Hydroxypropyl Methylcellulose, Magnesium Stearate, Methylparaben, PEG, Propylparaben, Stearic Acid.

Directions: ADULTS AND CHILDREN 12 YEARS AND OVER-- two tablets every 12 hours. Do not exceed four tablets in 24 hours.  CHILDREN UNDER 12 YEARS OF AGE:  consult a physician.

Store between 2° and 25°C (36° and 77°F). Protect from excessive moisture.

:    Do not exceed recommended dosage. If nervousness, dizziness, or sleeplessness occur, discontinue use and consult a doctor. If symptoms do not improve within 7 days, or are accompanied by fever that lasts for more than 3 days or recurs, consult a doctor before continuing use. If pain or fever persists or gets worse, if new symptoms occur, or if redness or swelling is present, consult a doctor because these could be signs of a serious condition. May cause excitability especially in children. Do not take this product if you have a breathing problem such as emphysema or chronic bronchitis, or if you have glaucoma, heart disease, high blood pressure, thryoid disease, diabetes, or difficulty in urination due to enlargement of the prostate gland, or give this product to children under 12 years of age, unless directed by a doctor. May cause drowsiness; alcohol, sedatives, and tranquilizers may increase the drowsiness effect. Avoid alcoholic beverages while taking this product. Do not take this product if you are taking sedatives or tranquilizers without first consulting your doctor. Use caution when driving a motor vehicle or operating machinery. As with any drug, if you are pregnant or nursing a baby, seek the advice of a health professional before using this product. Keep this and all drugs out of the reach of children. In case of accidental overdose, seek professional assistance or contact a Poison Control Center immediately. Prompt medical attention is critical for adults as well as for children even if you do not notice any signs or symptoms.

Alcohol Warning:   If you consume 3 or more alcoholic drinks every day, ask your doctor whether you should take acetaminophen or other pain relievers/fever reducers. Acetaminophen may cause liver damage.

Drug Interaction Precaution:   Do not use this product if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric or emotional conditions, or Parkinson' disease), or for 2 weeks after stopping the MAOI drug. If you are uncertain whether your prescription drug contains an MAOI, consult a health professional before taking this product.

How Supplied:   DRIXORAL® ALLERGY/SINUS Extended-Release Tablets are available in boxes of 12's and 24's.


NOTE: These photos can be used only for identification by shape, color, and imprint. They do not depict actual or relative size.

The product samples shown here have been supplied by the manufacturer and reproduced in full color by PDR as a quick-reference identification aid. While every effort has been made to assure accurate reproduction, please remember that any visual identification should be considered preliminary. In cases of poisoning or suspected overdosage, the drug' identity should be verified by chemical analysis.